Early appearance of activated matrix metalloproteinase-9 after focal cerebral ischemia in mice: A possible role in blood-brain barrier dysfunction

被引:333
|
作者
Gasche, Y
Fujimura, M
Morita-Fujimura, Y
Copin, JC
Kawase, M
Massengale, J
Chan, PH
机构
[1] Stanford Univ, Neurosurg Labs, Dept Neurosurg, Palo Alto, CA 94304 USA
[2] Stanford Univ, Neurosurg Labs, Dept Neurol & Neurol Sci, Palo Alto, CA 94304 USA
[3] Stanford Univ, Program Neurosci, Palo Alto, CA 94304 USA
来源
关键词
metalloproteinases; brain; ischemia; vasogenic edema; mice;
D O I
10.1097/00004647-199909000-00010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
During cerebral ischemia blood-brain barrier (BBB) disruption is a critical event leading to vasogenic edema and secondary brain injury. Gelatinases A and B are matrix metalloproteinases (MMP) able to open the BBB. The current study analyzes by zymography the early gelatinases expression and activation during permanent ischemia in mice (n = 15). ProMMP-9 expression was significantly (P < 0.001) increased in ischemic regions compared with corresponding contralateral regions after 2 hours of ischemia (mean 694.7 arbitrary units [AU], SD +/- 238.4 versus mean 107.6 AU, SD +/- 15.6) and remained elevated until 24 hours (mean 745.7 AU, SD +/- 157.4). Moreover, activated MMP-9 was observed 4 hours after the initiation of ischemia. At the same time as the appearance of activated MMP-9, we detected by the Evan's blue extravasation method a clear increase of BBB permeability. Tissue inhibitor of metalloproteinase-l was not modified during permanent ischemia at any time. The ProMMP-2 was significantly (P < 0.05) increased only after 24 hours of permanent ischemia (mean 213.2 AU, SD +/- 60.6 versus mean 94.6 AU, SD +/- 13.3), and no activated form was observed. The appearance of activated MMP-9 after 4 hours of ischemia in correlation with BBB permeability alterations suggests that MMP-9 may play an active role in early vasogenic edema development after stroke.
引用
收藏
页码:1020 / 1028
页数:9
相关论文
共 50 条
  • [21] Matrix metalloproteinase-9 is associated with blood-brain barrier opening and brain edema formation after cortical contusion in rats
    Shigemori, Y.
    Katayama, Y.
    Mori, T.
    Maeda, T.
    Kawamata, T.
    [J]. BRAIN EDEMA XIII, 2006, 96 : 130 - +
  • [22] Tissue plasminogen activator promotes matrix metalloproteinase-9 upregulation after focal cerebral ischemia
    Tsuji, K
    Aoki, T
    Tejima, E
    Arai, K
    Lee, SR
    Atochin, DN
    Huang, PL
    Wang, XY
    Montaner, J
    Lo, EH
    [J]. STROKE, 2005, 36 (09) : 1954 - 1959
  • [23] Blood-brain barrier disruption and matrix metalloproteinase-9 expression during, reperfusion injury - Mechanical versus embolic focal ischemia in spontaneously hypertensive rats
    Aoki, T
    Sumii, T
    Mori, T
    Wang, XY
    Lo, EH
    [J]. STROKE, 2002, 33 (11) : 2711 - 2717
  • [24] Pre-ischemic exercise reduces matrix metalloproteinase-9 expression and ameliorates blood-brain barrier dysfunction in stroke
    Guo, M.
    Cox, B.
    Mahale, S.
    Davis, W.
    Carranza, A.
    Hayes, K.
    Sprague, S.
    Jimenez, D.
    Ding, Y.
    [J]. NEUROSCIENCE, 2008, 151 (02) : 340 - 351
  • [25] Role of Hydrogen Sulfide in Early Blood-Brain Barrier Disruption following Transient Focal Cerebral Ischemia
    Jiang, Zheng
    Li, Chun
    Manuel, Morganne L.
    Yuan, Shuai
    Kevil, Christopher G.
    McCarter, Kimberly D.
    Lu, Wei
    Sun, Hong
    [J]. PLOS ONE, 2015, 10 (02):
  • [26] Contractile, but not endothelial, dysfunction in early inflammatory arthritis: a possible role for matrix metalloproteinase-9
    Reynolds, S. L.
    Williams, A. S.
    Williams, H.
    Smale, S.
    Stephenson, H. J.
    Amos, N.
    George, S. J.
    O'Donnell, V. B.
    Lang, D.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2012, 167 (03) : 505 - 514
  • [27] YiQiFuMai powder injection ameliorates blood-brain barrier dysfunction and brain edema after focal cerebral ischemia-reperfusion injury in mice
    Cao, Guosheng
    Ye, Xinyi
    Xu, Yingqiong
    Yin, Mingzhu
    Chen, Honglin
    Kou, Junping
    Yu, Boyang
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2016, 10 : 315 - 325
  • [28] Increased serum matrix metalloproteinase-9 in neuromyelitis optica: Implication of disruption of blood-brain barrier
    Hosokawa, Takafumi
    Nakajima, Hideto
    Doi, Yoshimitsu
    Sugino, Masakazu
    Kimura, Fumiharu
    Hanafusa, Toshiaki
    Takahashi, Toshiyuki
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2011, 236 (1-2) : 81 - 86
  • [29] Recombinant tissue plasminogen activator induces blood-brain barrier breakdown by a matrix metalloproteinase-9-independent pathway after transient focal cerebral ischemia in mouse
    Copin, Jean-Christophe
    Bengualid, Daniel Jimenez
    Da Silva, Rafaela F.
    Kargiotis, Odysseas
    Schaller, Karl
    Gasche, Yvan
    [J]. EUROPEAN JOURNAL OF NEUROSCIENCE, 2011, 34 (07) : 1085 - 1092
  • [30] Melatonin Preserves Blood-brain Barrier Integrity and Permeability via Matrix Metalloproteinase-9 Inhibition
    Shaji, Chinchusha Anasooya
    Alluri, Himakarnika
    Wiggins-Dohlvik, Katie
    Beeram, Madhava R.
    Davis, Matthew L.
    Tharakan, Binu L.
    [J]. FASEB JOURNAL, 2016, 30